Cor Vasa 2012, 54(11-12):e421-e427 | DOI: 10.1016/j.crvasa.2012.11.003
Quality of life and costs of conventional therapy in patients treated by catheter ablation for atrial fibrillation
- a II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha, Česká republika
- b International Clinical Research Center - I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny v Brně, Brno, Česká republika
- c Oddělení kardiologie, Kardiocentrum, Nemocnice Podlesí, a. s., Třinec, Česká republika
- d I. interní kardioangiologická klinika, Lékařská fakulta Univerzity Karlovy v Hradci Králové a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika
Aims: The purpose of the study was to assess quality of life, socioeconomic parameters, and costs of conventional therapy in patients treated by catheter ablation for atrial fibrillation (AF).
Methods: The study included 160 patients treated by catheter ablation for AF who fulfilled a minimum of 2-year follow-up. Quality of life using EQ-5D questionnaire, and days of hospitalization and working incapacity were evaluated before ablation and every 6 months after ablation. Further, one-year costs of conventional therapy for AF were assessed before and after ablation.
Results: Quality of life was significantly improved at each post-ablation stage. EQ-5D index increased from baseline 68 ± 14 to 76 ± 17 after 2 years (p < 0.001), and EQ-VAS score from baseline 65 ± 17 to 71 ± 15 after 2 years (p = 0.01). Significant reduction was further observed in the count of hospitalization days and days of working incapacity (both p < 0.01). The cost of conventional therapy per patient per year decreased from 49,337 Czech crowns (1974 €) before ablation to 16,504 CZC (660 €) and 13,576 CZC (543 €) in the first and second post-ablation year, respectively.
Conclusion: AF ablation was associated with significant improvement in quality of life, and decrease in days of hospitalization and working incapacity. There was more than three-fold reduction in the costs of conventional therapy observed in the first two years after ablation.
Keywords: Atrial fibrillation; Catheter ablation; Conventional therapy; Costs of therapy; Quality of life
Received: September 25, 2012; Revised: November 6, 2012; Accepted: November 7, 2012; Published: November 1, 2012 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- T.S. Tsang, G.W. Petty, M.E. Barnes, et al., The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades, Journal of the American College of Cardiology 42 (2003) 93-100.
Go to original source...
Go to PubMed...
- Y. Miyasaka, M.E. Barnes, B.J. Gersh, et al., Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projection for future prevalence, Circulation 114 (2006) 119-125.
Go to original source...
Go to PubMed...
- W. Greiner, T. Weijnen, M. Nieuwenhuizen, et al., A single European currency for EQ-5D health states. Results from a six country study, European Journal of Health Economics 4 (2003) 222-231.
Go to original source...
Go to PubMed...
- R. Cappato, H. Calkins, S.A. Chen, et al., Worldwide survey on the methods. Efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation 111 (2005) 1100-1105.
Go to original source...
Go to PubMed...
- R. Cappato, H. Calkins, S.A. Chen, et al., Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation 3 (2010) 32-38.
Go to original source...
Go to PubMed...
- C. Pappone, S. Rosanio, G. Augello, et al., Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study, Journal of the American College of Cardiology 42 (2003) 185-197.
Go to original source...
Go to PubMed...
- O.M. Wazni, N.F. Marrouche, D.O. Martin, et al., Radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial, The Journal of the American Medical Association 293 (2005) 2634-2640.
Go to original source...
Go to PubMed...
- P. Jais, B. Cauchemez, L. Macle, et. al., Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation 118 (2008) 2498-2505.
Go to original source...
Go to PubMed...
- D.J. Wilber, C. Pappone, P. Neuzil, et al., Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial, The Journal of the American Medical Association 303 (2010) 333-340.
Go to original source...
Go to PubMed...
- A. Wokhlu, K.H. Monahan, D.O. Hodge, et al., Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence symptom relief, and placebo effect, Journal of the American College of Cardiology 55 (2010) 2309-2316.
Go to original source...
Go to PubMed...
- C. Pappone, G. Vicedomini, G. Augello, et al., Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: The APAF Study, Circulation. Arrhythmia and Electrophysiology 4 (2011) 808-814.
Go to original source...
Go to PubMed...
- V. Bulková, M. Fiala, J. Chovančík, et al., Analýza nákladů na léčbu u pacientů s fibrilací síní v České republice, Cor et Vasa 50 (2008) 23-27.
Go to original source...
- J.Y. Le Heuzey, O. Paziaud, O. Piot, et al., Cost of care distribution in atrial fibrillation patients: the COCAF study, American Heart Journal 147 (2004) 121-126.
Go to original source...
Go to PubMed...
- K. Moeremans, E. Aliot, C. Chillou, et al., Second line pharmacological management of paroxysmal and persistent atrial fibrillation in France: a cost analysis, Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 6 (2000) 407-416.
Go to original source...
Go to PubMed...
- L.F. Hsu, P. Jaïs, P. Sanders, et al., Catheter ablation for atrial fibrillation in congestive heart failure, The New England Journal of Medicine 351 (2004) 2373-2383.
Go to original source...
Go to PubMed...
- P.J. Gentlesk, W.H. Sauer, E.P. Gerstenfeld, et al., Reversal of left ventricular dysfunction following ablation of atrial fibrillation, Journal of Cardiovascular Electrophysiology 18 (2007) 9-14.
Go to original source...
Go to PubMed...
- P.S. Chan, S. Vijan, F. Morady, et al., Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation, Journal of the American College of Cardiology 47 (2006) 2513-2520.
Go to original source...
Go to PubMed...